Severe bacterial non-aids infections in HIV-positive persons: Incidence rates and risk factors

Journal of Infection

Volumn 66, Issue 5, 2013, Pages 439-446

  Sogaard O S ^a   Reekie, J ^b   Ristola, M ^c   Jevtovic, D ^d   Karpov, I ^e   Beniowski, M ^f   Servitskiy, S ^g   Domingo, P ^h   Reiss, P ⁱ   Mocroft, A ^b   Kirk, O ^j,k  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d Institute for Infectious and Tropical Diseases   (Serbia)

^e BELARUSIAN STATE MEDICAL UNIVERSITY   (Belarus)

^f Specialistic Hospital   (Poland)

^g Odessa Region AIDS Centre   (Ukraine)

^h HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

ⁱ UNIVERSITY OF AMSTERDAM   (Netherlands)

^j International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^k UNIVERSITY OF COPENHAGEN   (Denmark)

more..

Author keywords

Antiretroviral therapy; Comorbidity; Epidemiology; HIV; Infections

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANEMIA; ARGENTINA; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; ENDOCARDITIS; EUROPE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; ISRAEL; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MORBIDITY; OSTEITIS; PERITONITIS; PNEUMONIA; PROSPECTIVE STUDY; PYELONEPHRITIS; RISK FACTOR; SEVERE BACTERIAL NON AIDS INFECTION; SEX DIFFERENCE;

ADULT; ARGENTINA; BACTERIAL INFECTIONS; COHORT STUDIES; EUROPE; FEMALE; HIV INFECTIONS; HOSPITALIZATION; HUMANS; INCIDENCE; ISRAEL; MALE; MIDDLE AGED; POISSON DISTRIBUTION; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84875615299     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.12.012     Document Type: Article

References (32)

1. Gandhi T., Wei W., Amin K., Kazanjian P. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy. Clin Infect Dis 2006, 42:878-884.
2. Deeks S.G., Phillips A.N. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ 2009, 338:a3172.
3. Mocroft A., Reiss P., Gasiorowski J., Ledergerber B., Kowalska J., Chiesi A., et al. Serious fatal and nonfatal non-AIDS-defining illnesses in Europe. J Acquir Immune Defic Syndr 2010, 55:262-270.
4. Weber R., Sabin C.A., Friis-Moller N., Reiss P., El-Sadr W.M., Kirk O., et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A:D study. Arch Intern Med 2006, 166:1632-1641.
5. Grulich A.E., van Leeuwen M.T., Falster M.O., Vajdic C.M. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007, 370:59-67.
6. Kohli R., Lo Y., Homel P., Flanigan T.P., Gardner L.I., Howard A.A., et al. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study. Clin Infect Dis 2006, 43:90-98.
7. Sogaard O.S., Lohse N., Gerstoft J., Kronborg G., Ostergaard L., Pedersen C., et al. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study. Clin Infect Dis 2008, 47:1345-1353.
8. Domingo P., Suarez-Lozano I., Torres F., Pomar V., Ribera E., Galindo M.J., et al. Bacterial meningitis in HIV-1-infected patients in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2009, 51:582-587.
9. Grau I., Pallares R., Tubau F., Schulze M.H., Llopis F., Podzamczer D., et al. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Arch Intern Med 2005, 165:1533-1540.
10. Mocroft A., Ledergerber B., Katlama C., Kirk O., Reiss P., d'Arminio Monforte A., et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003, 362:22-29.
11. International Classification of Diseases (ICD). 10th revision; 2011. [accessed 06.12.11]. http://www.who.int/classifications/icd/en/.
12. Lundgren J.D., Phillips A.N., Vella S., Katlama C., Ledergerber B., Johnson A.M., et al. Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 16:153-160.
13. Reekie J., Gatell J.M., Yust I., Bakowska E., Rakhmanova A., Losso M., et al. Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata. AIDS 2011, 25:2259-2268.
14. Reekie J., Kosa C., Engsig F., Monforte A., Wiercinska-Drapalo A., Domingo P., et al. Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies. Cancer 2010, 116:5306-5315.
15. Mocroft A., Reiss P., Gasiorowski J., Ledergerber B., Kowalska J., Chiesi A., et al. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. Aids 2010, 24:1667-1678.
16. Mocroft A., Kirk O., Reiss P., De Wit S., Sedlacek D., Beniowski M., et al. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 2011, 53:1130-1139.
17. Sullivan J.H., Moore R.D., Keruly J.C., Chaisson R.E. Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection. Am J Respir Crit Care Med 2000, 162:64-67.
18. Hirschtick R.E., Glassroth J., Jordan M.C., Wilcosky T.C., Wallace J.M., Kvale P.A., et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary complications of HIV Infection Study Group. New Engl J Med 1995, 333:845-851.
19. Tumbarello M., Tacconelli E., de Gaetano K., Ardito F., Pirronti T., Cauda R., et al. Bacterial pneumonia in HIV-infected patients: analysis of risk factors and prognostic indicators. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 18:39-45.
20. Crothers K., Huang L., Goulet J.L., Goetz M.B., Brown S.T., Rodriguez-Barradas M.C., et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med 2011, 183:388-395.
21. Curran A., Falco V., Crespo M., Martinez X., Ribera E., Villar del Saz S., et al. Bacterial pneumonia in HIV-infected patients: use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome. HIV Med 2008, 9:609-615.
22. Gordin F.M., Roediger M.P., Girard P.M., Lundgren J.D., Miro J.M., Palfreeman A., et al. Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption. Am J Respir Crit Care Med 2008, 178:630-636.
23. El-Sadr W.M., Lundgren J.D., Neaton J.D., Gordin F., Abrams D., Arduino R.C., et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 2006, 355:2283-2296.
24. Prezant D.J. Effect of uremia and its treatment on pulmonary function. Lung 1990, 168:1-14.
25. Vaziri N.D., Pahl M.V., Crum A., Norris K. Effect of uremia on structure and function of immune system. J Ren Nutr 2012, 22:149-156.
26. Girndt M., Sester M., Sester U., Kaul H., Kohler H. Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl 2001, 78:S206-S211.
27. Kornum J.B., Thomsen R.W., Riis A., Lervang H.H., Schonheyder H.C., Sorensen H.T. Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study. Diabetes Care 2008, 31:1541-1545.
28. Thomsen R.W., Hundborg H.H., Lervang H.H., Johnsen S.P., Schonheyder H.C., Sorensen H.T. Diabetes mellitus as a risk and prognostic factor for community-acquired bacteremia due to enterobacteria: a 10-year, population-based study among adults. Clin Infect Dis 2005, 40:628-631.
29. Thomsen R.W., Riis A.H., Kjeldsen S., Schonheyder H.C. Impact of diabetes and poor glycaemic control on risk of bacteraemia with haemolytic streptococci groups A, B, and G. J Infect 2011.
30. Coenen T., Lundgren J., Lazarus J.V., Matic S. Optimal HIV testing and earlier care: the way forward in Europe. HIV Med 2008, 9(Suppl. 2):1-5.
31. Pedersen R., Lohse N., Ostergaard L., Sogaard O. The effectiveness of pneumococcal polysaccharide vaccination in HIV-infected adults: a systematic review. HIV Med 2011, 12:323-333.
32. Barry P.M., Zetola N., Keruly J.C., Moore R.D., Gebo K.A., Lucas G.M. Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990-2003. AIDS (London, England) 2006, 20:437-444.